Replimune Group Inc (REPL)

Dec 20, 2024

Replimune Group (NASDAQ:REPL) Stock Price Up 8.2%Here's Why - MarketBeat

Dec 20, 2024

Dec 20, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 6,759 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Dec 20, 2024

Dec 18, 2024

Insider Selling: Replimune Group, Inc. (NASDAQ:REPL) CEO Sells 10,000 Shares of Stock - MarketBeat

Dec 18, 2024

Dec 18, 2024

Replimune CEO Sushil Patel sells $124,200 in company stock - Investing.com

Dec 18, 2024

Dec 18, 2024

Replimune CEO Sushil Patel sells $124,200 in company stock By Investing.com - Investing.com UK

Dec 18, 2024

Dec 18, 2024

Wellington Management Group LLP Decreases Stake in Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat

Dec 18, 2024

Dec 18, 2024

BNP Paribas Financial Markets Buys 6,748 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Dec 18, 2024

Dec 17, 2024

Replimune Group (NASDAQ:REPL) Trading Down 4.7%Here's Why - MarketBeat

Dec 17, 2024

Dec 16, 2024

When (REPL) Moves Investors should Listen - Stock Traders Daily

Dec 16, 2024

Dec 15, 2024

Replimune's SWOT analysis: biotech's melanoma treatment stock nears key milestones By Investing.com - Investing.com South Africa

Dec 15, 2024

Dec 15, 2024

Replimune's SWOT analysis: biotech's melanoma treatment stock nears key milestones - Investing.com India

Dec 15, 2024

Dec 14, 2024

Replimune Group, Inc. (NASDAQ:REPL) Short Interest Down 16.5% in November - MarketBeat

Dec 14, 2024

Dec 13, 2024

Fmr LLC Sells 120,776 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Dec 13, 2024

Dec 13, 2024

Fmr LLC Has $6.87 Million Position in Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat

Dec 13, 2024

Dec 13, 2024

Charles Schwab Investment Management Inc. Buys 52,498 Shares of Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat

Dec 13, 2024

Dec 13, 2024

Charles Schwab Investment Management Inc. Purchases 52,498 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Dec 13, 2024

Dec 10, 2024

Jacobs Levy Equity Management Inc. Sells 44,153 Shares of Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat

Dec 10, 2024

Dec 10, 2024

The Manufacturers Life Insurance Company Increases Stock Holdings in Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Dec 10, 2024

Dec 07, 2024

Replimune Group, Inc. (NASDAQ:REPL) Receives $17.29 Average PT from Analysts - MarketBeat

Dec 07, 2024

Dec 06, 2024

Intech Investment Management LLC Buys New Stake in Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Dec 06, 2024

Dec 06, 2024

Where are the Opportunities in (REPL) - Stock Traders Daily

Dec 06, 2024

Dec 05, 2024

Replimune Group, Inc. (NASDAQ:REPL) Holdings Reduced by Redmile Group LLC - MarketBeat

Dec 05, 2024

Dec 04, 2024

Parkman Healthcare Partners LLC Buys 238,747 Shares of Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat

Dec 04, 2024

Dec 03, 2024

Replimune stock target raised to $19 on BLA submission By Investing.com - Investing.com Canada

Dec 03, 2024

Dec 02, 2024

Baker BROS. Advisors LP Has $121.06 Million Stake in Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat

Dec 02, 2024

Dec 01, 2024

Replimune Group, Inc. (NASDAQ:REPL) Shares Sold by Algert Global LLC - MarketBeat

Dec 01, 2024

Nov 30, 2024

Braidwell LP Acquires 2,057,460 Shares of Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat

Nov 30, 2024

Nov 29, 2024

Replimune Group Announces Pricing of Public Offering - Defense World

Nov 29, 2024

Nov 29, 2024

Replimune: RPL1 BLA Submission Under AA Pathway Makes It A Must Watch - Seeking Alpha

Nov 29, 2024

Nov 28, 2024

Replimune Group Amends Sales Agreement with Leerink Partners LLC - Defense World

Nov 28, 2024

Nov 26, 2024

Replimune reduces offering size in amended sales agreement - Investing.com

Nov 26, 2024

Nov 26, 2024

Replimune reduces offering size in amended sales agreement By Investing.com - Investing.com Australia

Nov 26, 2024

Nov 26, 2024

SEC Form 424B5 filed by Replimune Group Inc. - Quantisnow

Nov 26, 2024

Nov 26, 2024

Cancer firm Replimune readies $125 million offering - The Pharma Letter

Nov 26, 2024

Nov 26, 2024

REPLReplimune Group, Inc. Latest Stock News & Market Updates - StockTitan

Nov 26, 2024

Nov 26, 2024

Replimune announces $125 million public offering By Investing.com - Investing.com South Africa

Nov 26, 2024

Nov 26, 2024

Replimune's SWOT analysis: stock outlook as RP1 nears key milestones By Investing.com - Investing.com Canada

Nov 26, 2024

Nov 26, 2024

Replimune Announces Pricing of Upsized Public Offering - The Manila Times

Nov 26, 2024

Nov 26, 2024

Replimune Prices $140M Upsized Public Offering of Common Stock & Warrants | REPL Stock News - StockTitan

Nov 26, 2024

Nov 25, 2024

Replimune's SWOT analysis: stock outlook as RP1 nears key milestones - Investing.com

Nov 25, 2024

Nov 25, 2024

How to Take Advantage of moves in (REPL) - Stock Traders Daily

Nov 25, 2024

Nov 25, 2024

Replimune announces $125 million public offering - Investing.com India

Nov 25, 2024

Nov 25, 2024

Replimune Announces Proposed Public Offering - The Manila Times

Nov 25, 2024

Nov 25, 2024

Canadian Dollar/Japanese Yen (CADJPY) QuotePress Release - The Globe and Mail

Nov 25, 2024

Nov 25, 2024

Replimune Group (NASDAQ:REPL) Price Target Raised to $18.00 - Defense World

Nov 25, 2024

Nov 24, 2024

Replimune Group (NASDAQ:REPL) Earns Buy Rating from HC Wainwright - Defense World

Nov 24, 2024

Nov 23, 2024

Replimune's stock surges 19% after-hours on FDA BLA submission - MSN

Nov 23, 2024

Nov 23, 2024

Replimune Group (NASDAQ:REPL) Reaches New 52-Week High on Analyst Upgrade - MarketBeat

Nov 23, 2024

Nov 23, 2024

BMO Capital Markets Increases Replimune Group (NASDAQ:REPL) Price Target to $18.00 - MarketBeat

Nov 23, 2024

Nov 23, 2024

Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry? - Simply Wall St

Nov 23, 2024